mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.41 |
0.008 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.008 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.009 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.01 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.01 |
mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
0.38 |
0.02 |
mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
0.38 |
0.02 |